Gliomas are frequently characterized by dysregulated signaling downstream of growth factor receptors such as EGFR, PDGFR, and IGFR, and elevated production of their corresponding ligands [3]–[6]. The gene discussed is IGF1R; the disease is central nervous system cancer.